Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > UT researchers' innovation addresses major challenge of drug delivery

Abstract:
A new physical form of proteins developed by researchers at The University of Texas at Austin could drastically improve treatments for cancer and other diseases, as well as overcome some of the largest challenges in therapeutics: delivering drugs to patients safely, easily and more effectively.

UT researchers' innovation addresses major challenge of drug delivery

Austin, TX | Posted on January 28th, 2012

The protein formulation strategy, developed by faculty and students in the Cockrell School of Engineering's Department of Chemical Engineering, is unprecedented and offers a new and universal approach to drug delivery - one that could revolutionize treatment of cancer, arthritis and infectious disease.

"We believe this discovery of a new highly concentrated form of proteins - clusters of individual protein molecules - is a disruptive innovation that could transform how we fight diseases," said Keith P. Johnston, a chemical engineering professor and member of the National Academy Engineering. "It required integration of challenging contributions in fundamental science and engineering from three of our chemical engineering research groups."

The research, led by Johnston, Chemical Engineering Professor Thomas M. Truskett and Assistant Professor Jennifer Maynard, was published online recently ahead of a print version to appear soon in the ACS Nano journal.

"The real challenge in developing therapeutics is how do you deliver them to patients." Maynard said.

Typically, protein biopharmaceuticals are administered intravenously at dilute concentrations in a hospital or clinic. Scientists and engineers have long tried to produce safe drugs at higher concentrations, so that a patient could self-inject the drugs at home, similar to an insulin shot. But doing so has been stymied by the fact that proteins, in high-concentration formulations, form aggregates that could be dangerous to patients and gels that cannot be injected.

The Cockrell School research team has introduced a new physical form of proteins, whereby proteins are packed into highly concentrated, nanometer-sized clusters that can pass through a needle into a patient to treat disease. The novel composition avoids the pitfalls of previous attempts because drug proteins are clustered so densely that they don't unfold or form dangerous aggregates.

"This general physical concept for forming highly concentrated, yet stable, protein dispersions is a major new direction in protein science," Johnston said.

A key advance came in 2004, when Truskett predicted that protein-based drugs in solution would be stable if they could somehow be formulated at ultra-high concentrations. At that time, Johnston had nanoparticles of concentrated stable protein but didn't know how to disperse them in an injectable form.

In 2009, the team formed protein nanoclusters in water simply by properly adjusting the pH (to lower protein charge) and adding sugar to crowd protein molecules together. Upon dilution or subcutaneous injection into a mouse the proteins separate back to individual stable molecules with biological activity. Once injected, the protein in the bloodstream attacks targeted cells and tumors similarly as for protein delivered via IV therapy. To provide a roadmap for improving the design of nanoclusters, chemical engineering graduate students, Andrea Miller and Ameya Borwankar worked with Truskett and Johnston to develop a new thermodynamic theory.

Another breakthrough for the team came in 2009 when a chemical engineering senior, Brian Wilson, created a transparent dispersion of extremely concentrated protein, which was later found to be formed of nanoclusters.

"Through Brian's discussions about the research both inside and outside of the classroom, numerous undergraduate students at UT are now realizing the enormous opportunities they have to contribute to science, engineering and human health when they get involved in research projects," Johnston said.

Since the research began in 2004, three patent applications have been filed through the university's Office of Technology Commercialization.

The research is funded by the National Science Foundation, the National Institutes of Health, the Welch Foundation, and the Packard Foundation. Starting in 2012, two major pharmaceutical companies will fund the work.

####

For more information, please click here

Contacts:
Melissa Mixon

512-471-2129

Copyright © University of Texas at Austin

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

New method in the fight against forever chemicals September 13th, 2024

Energy transmission in quantum field theory requires information September 13th, 2024

Breakthrough in proton barrier films using pore-free graphene oxide: Kumamoto University researchers achieve new milestone in advanced coating technologies September 13th, 2024

Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024

Govt.-Legislation/Regulation/Funding/Policy

Giving batteries a longer life with the Advanced Photon Source: New research uncovers a hydrogen-centered mechanism that triggers degradation in the lithium-ion batteries that power electric vehicles September 13th, 2024

New discovery aims to improve the design of microelectronic devices September 13th, 2024

Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024

Single atoms show their true color July 5th, 2024

Nanomedicine

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

Discoveries

Energy transmission in quantum field theory requires information September 13th, 2024

Breakthrough in proton barrier films using pore-free graphene oxide: Kumamoto University researchers achieve new milestone in advanced coating technologies September 13th, 2024

Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024

New nanomaterial could transform how we visualise fingerprints: Innovative nanomaterials have the potential to revolutionise forensic science, particularly in the detection of latent (non-visible) fingermarks September 13th, 2024

Announcements

Giving batteries a longer life with the Advanced Photon Source: New research uncovers a hydrogen-centered mechanism that triggers degradation in the lithium-ion batteries that power electric vehicles September 13th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

New discovery aims to improve the design of microelectronic devices September 13th, 2024

New method in the fight against forever chemicals September 13th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project